Global Neurology Academy

Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiers
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- Kelly Sloane, MD
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Neurology and Neurosurgery
Mapping Brain Atrophy in Schizophrenia
- Ahmed Makhlouf, MD
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD

Medical News

Medical News
Open-World Video Games Found to Boost Mental Well-Being in Postgraduate Students
medicalxpress.com
01/08/2025
Read more
Medical News
Innovative Haptic Belt Shows Promise for Improving Mobility in People With Vision Loss
sciencedaily.com
01/08/2025
Read more
Medical News
Socioeconomic Factors Tied to Brain Lesion Severity in Pediatric MS
medicalxpress.com
01/08/2025
Read more
Medical News
Smartphone App Reduces Opioid Use and Enhances Treatment Retention, Study Finds
news.uthscsa.edu
01/07/2025
Read more

See more news

CME/CE

Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 program credits
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
MinuteCE®
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
MinuteCE®
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
1.25 credits 11 episodes
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 credits 11 episodes
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits

Clinical Practice

Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Global Neurology Academy
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
- Mark Gudesblatt, MD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD

Programs

Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD